Epistaxis medical therapy: Difference between revisions
Kiran Singh (talk | contribs) |
m (Bot: Removing from Primary care) |
||
Line 30: | Line 30: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Otolaryngology]] | [[Category:Otolaryngology]] | ||
[[Category:Rhinology]] | [[Category:Rhinology]] | ||
[[Category:First aid]] | [[Category:First aid]] | ||
[[Category:Injuries]] | [[Category:Injuries]] | ||
[[Category:Needs overview]] | [[Category:Needs overview]] | ||
Revision as of 21:37, 29 July 2020
Epistaxis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Epistaxis medical therapy On the Web |
American Roentgen Ray Society Images of Epistaxis medical therapy |
Risk calculators and risk factors for Epistaxis medical therapy |
Editor in Chief: Liudvikas Jagminas, M.D., FACEP [1] Phone: 401-729-2419
Medical Therapy
The flow of blood normally stops when the blood clots, which may be encouraged by direct pressure applied by pinching the soft fleshy part of the nose. This applies pressure to Little's area, the source of the majority of nose bleeds and promotes clotting. Pressure should be firm and be applied for at least 10 minutes while keeping the head in the neutral position and spitting out any blood which flows into the mouth. There is no benefit to pinching the bridge of the nose or to tilting the head backwards or forwards. Swallowing excess blood can irritate the stomach and cause vomiting. Local application of an ice pack to the forehead or back of the neck or sucking an ice cube has seen widespread practice, but has been shown to not have any statistically significant effects on nasal mucosal blood flow.[1] In the past, it was commonly thought that the ice would help by promoting constriction of local blood vessels and thus reducing blood flow to slow down the bleed. Do not pack the nose with tissues or gauze. [2]
The local application of a vasoconstrictive agent has been shown to reduce the bleeding time in benign cases of epistaxis. The drugs oxymetazoline or phenylephrine are widely available in over-the-counter nasal sprays for the treatment of allergic rhinitis, and may be used for this purpose.[3]
Other products available that promote coagulation include Coalgan (in Europe) or NasalCEASE (in the US). These are a calcium alginate meshes that are inserted in the nasal cavity to accelerate coagulation.
If these simple measures do not work, then medical intervention may be needed to stop bleeding, possibly by an otolaryngologist (ENT doctor). In the first instance this can take the form of chemical cautery of any bleeding vessels or packing of the nose with ribbon gauze or an absorbent dressing. Such procedures are best carried out by a medical professional. Chemical cauterization is most commonly conducted using local application of a silver nitrate compound to any visible bleeding vessel. This is a painful procedure and the nasal mucosa should be anesthetized first, preferably with the addition of topical adrenaline to further reduce bleeding. If bleeding is still uncontrolled or no focal bleeding point is visible then the nasal cavity should be packed with a sterile dressing, which by applying pressure to the nasal mucosa will tamponade the bleeding point. Ongoing bleeding, despite good nasal packing, is a surgical emergency and can be treated by endoscopic evaluation of the nasal cavity under general anesthesia to identify an elusive bleeding point or to directly ligate (tie off) the blood vessels supplying the nose. These blood vessels include the sphenopalatine, anterior and posterior ethmoidal arteries. More rarely the maxillary or external carotid artery can be ligated. The bleeding can also be stopped by intra-arterial embolization using a catheter placed in the groin and threaded up the aorta to the bleeding vessel by an interventional radiologist. Continued bleeding may be an indication of more serious underlying conditions.[4]
Chronic epistaxis resulting from a dry nasal mucosa can be treated by spraying saline in the nose up to three times per day.
Application of a topical antibiotic ointment to the nasal mucosa has been shown to be an effective treatment for recurrent epistaxis.[5] One study found it to be as effective as nasal cautery in the prevention of recurrent epistaxis in patients without active bleeding at the time of treatment (both had a success rate of approximately 50 percent.)[6]
Nosebleeds are rarely dangerous unless prolonged and heavy. Nevertheless they should not be underestimated by medical staff. Particularly in posterior bleeds a great deal of blood may be swallowed and thus blood loss underestimated. The elderly and those with co-existing morbidities, particularly of blood clotting should be closely monitored for signs of shock.
Recurrent nosebleeds may cause anemia due to iron deficiency.
As a summary; first aid of epistaxis includes:
- Tilt head forward, apply continuous pressure by pinching nares together to avoid posterior blood drainage (5-10 minutes)
- Apply silver nitrate to bleeding vessel (if identified)
- Possible blood transfusions
- Platelet transfusion, vitamin K, fresh frozen plasma, clottin factor replacement for bleeding disorders (if necessary)
- Possible ENT consult
References
- ↑ IngentaConnect Efficacy of ice packs in the management of epistaxis
- ↑ "Rush University Medical Center". Retrieved 2008-03-05.
- ↑ Guarisco JL, Graham HD (1989). "Epistaxis in children: causes, diagnosis, and treatment". Ear Nose Throat J. 68 (7): 522, 528–30, 532 passim. PMID 2676467.
- ↑ MedlinePlus Medical Encyclopedia: Nosebleed
- ↑ Kubba H, MacAndie C, Botma M, Robison J, O'Donnell M, Robertson G, Geddes N (2001). "A prospective, single-blind, randomized controlled trial of antiseptic cream for recurrent epistaxis in childhood". Clin Otolaryngol Allied Sci. 26 (6): 465–8. PMID 11843924.
- ↑ Murthy P, Nilssen EL, Rao S, McClymont LG (1999). "A randomised clinical trial of antiseptic nasal carrier cream and silver nitrate cautery in the treatment of recurrent anterior epistaxis". Clin Otolaryngol Allied Sci. 24 (3): 228–31. PMID 10384851.